| Recruiting | Mechanisms of Maternal Immune Tolerance in Early Pregnancy NCT07297394 | University Hospital, Basel, Switzerland | — |
| Recruiting | Immune Tolerance Induction After Liver Transplantation NCT07269041 | University of California, Los Angeles | Phase 1 / Phase 2 |
| Active Not Recruiting | TRAnscriptional Profile of Peripheral Blood Cells in Patient With Chronic Kidney and Lung Rejection: Correlati NCT07316829 | Fondazione IRCCS Policlinico San Matteo di Pavia | — |
| Not Yet Recruiting | Efficacy and Safety of Immunosuppressive Withdrawal After Pediatric Liver Transplantation NCT06147375 | Wei Gao | N/A |
| Terminated | Improving KIdney Transplantation with Cellular Therapy Study NCT06243289 | Western Sydney Local Health District | — |
| Unknown | Immune Tolerance After Pediatric Liver Transplantation NCT05501301 | RenJi Hospital | — |
| Terminated | Long-term Safety Follow-up in Recipients Who Previously Received Medeor's Cellular Immunotherapy Products NCT05010174 | Medeor Therapeutics, Inc. | — |
| Enrolling By Invitation | Kidney and Hematopoietic Cell Transplants Using a Regimen to Promote Hematopoietic Cell Engraftment NCT04571203 | Stanford University | Phase 1 |
| Unknown | Clinico-immunological Characterization and Immune Tolerance Breakdown in HU-autoimmunity NCT05745792 | Hospices Civils de Lyon | — |
| Completed | Andosan in Allergic and Asthma Patients NCT05192720 | University Hospital, Akershus | N/A |
| Unknown | The Correlation Between Immunological Reaction of the Seminal Fluid in the Mother's Blood and Pregnancy Compli NCT04314518 | Sheba Medical Center | — |
| Completed | Immune Responses With Reduxium NCT04525456 | Ogevity Therapeutics, Inc. | N/A |
| Unknown | Preventing Inhibitor Recurrence Indefinitely NCT04621916 | Children's Hospital Los Angeles | Phase 4 |
| Completed | Origin of CEC in Patients After Allo-HSCT NCT04038827 | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | — |
| Unknown | Delayed Blood Stem Transplantation in HLA Matched Kidney Transplant Recipients to Eliminate Immunosuppressive NCT03591302 | Stephan Busque | Phase 1 |
| Completed | Immune Response to BCG Vaccination in Neonates Born to HIV and LTBI Infected and Non-infected Mothers NCT03383211 | George Washington University | — |
| Unknown | Inducing Graft Tolerance in HLA Haplotype Matched Related and 3 Ag Matched Unrelated Living Donor Kidney Trans NCT03292445 | Samuel Strober | EARLY_Phase 1 |
| Unknown | Intra-peritoneal Chemotherapy in Ovarian Cancer NCT02861872 | Radboud University Medical Center | — |
| Completed | The Effects of Preceding LPS Administration on the Fluenz-induced Immune Response NCT02642237 | Radboud University Medical Center | N/A |
| Completed | Liver Immune Tolerance Marker Utilization Study NCT02541916 | University of Toronto | N/A |
| Unknown | Immune Responses in Hen's Egg Oral Immunotherapy NCT03744325 | Helsinki University Central Hospital | N/A |
| Completed | Effect of Intralymphatic Immunotherapy NCT02255604 | University of Aarhus | Phase 2 |
| Completed | The Evolution of Relationship Between Results of Peripheral Blood Test and Outcomes of in Vitro Fertilization NCT03103113 | Yeh | — |
| Completed | Immunologic Profile of Children With Severe Allergies to Peanuts and Nuts After Induction of Tolerance NCT01996774 | Lille Catholic University | — |
| Completed | Vitamin D Supplementation and Regulatory FoxP3+ T Cells in the GUT NCT01538485 | Medical University of Graz | Phase 4 |
| Unknown | Immune Function in Patients With Obstructive Jaundice NCT01367821 | University of Nottingham | — |
| Unknown | The Immune Tolerance Mechanism Induced by IL-17-producing Regulatory T Cells in the Orthotopic Liver Transplan NCT01117077 | Shanghai Jiao Tong University School of Medicine | — |
| Completed | Pneumococcal Conjugate Vaccine Followup NCT01414504 | William Pomat | Phase 2 |
| Completed | HEart trAnsplantation Registry of piTie-Salpetriere University Hospital NCT03393793 | Lee S Nguyen | — |
| Active Not Recruiting | Kidney and Blood Stem Cell Transplantation That Eliminates Requirement for Immunosuppressive Drugs NCT00319657 | Stanford University | Phase 1 / Phase 2 |